Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer
scientific article published on 20 April 2020
Author/s
author: Lillian M Smyth, Kenji Tamura, Mafalda Oliveira, Eva M Ciruelos, Jack Ashton, Justin Lindemann, Udai Banerji, Maurizio Scaltriti, Sarat Chandarlapaty, Barry S. Taylor, Ingrid A. Mayer
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.